Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SCFAS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| alpha-synuclein aggregation | inhibits | process | 0.80 |
| neuroinflammation | inhibits | process | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Physiological SCFAs may confer indirect anti-synuclein benef | 0.670 | neurodegeneration | Do physiological concentrations of SCFAs |
| Physiological SCFAs may reduce alpha-synuclein burden primar | 0.650 | neurodegeneration | Do physiological concentrations of SCFAs |
| The most realistic translational use of physiological SCFAs | 0.610 | neurodegeneration | Do physiological concentrations of SCFAs |
| Physiological SCFAs may worsen alpha-synuclein pathology thr | 0.550 | neurodegeneration | Do physiological concentrations of SCFAs |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SCFAS in their description or question text
No additional research found